FOXM1-activated SIRT4 inhibits NF-κB signaling and NLRP3 inflammasome to alleviate kidney injury and podocyte pyroptosis in diabetic nephropathy
- PMID: 34626587
- DOI: 10.1016/j.yexcr.2021.112863
FOXM1-activated SIRT4 inhibits NF-κB signaling and NLRP3 inflammasome to alleviate kidney injury and podocyte pyroptosis in diabetic nephropathy
Abstract
Forkhead box M1 (FOXM1) has been reported to play a protective role against acute kidney injury by driving tubular regeneration. This study aims to probe the function of FOXM1 in diabetic nephropathy (DN) and the molecules involved. FOXM1 was poorly expressed in DN-diseased kidney tissues. A murine model of DN was established, and podocytes cells (MPC5) were treated with high-glucose (HG) for in vitro studies. FOXM1 overexpression improved kidney function and reduced pathological changes in mice, and it increased the expression of the podocyte marker Nephrin in kidney tissues. In vitro, FOXM1 increased viability and reduced pyroptosis of the HG-treated MPC5 cells, and it elevated the expression of the podocyte marker Nephrin whereas reduced the expression of pyroptosis-related NLRP3 inflammasome and cleaved caspase 1. FOXM1 bound to the promoter of sirtuin 4 (SIRT4) to induce transcriptional activation. Downregulation of SIRT4 blocked the protective roles of FOXM1 both in vivo and in vitro. Phosphorylation of nuclear factor-kappa B (NF-κB) in HG-treated cells was suppressed by FOXM1 but restored after SIRT4 inhibition. In conclusion, this study suggested that FOXM1 transcriptionally activates SIRT4 and inhibits NF-κB signaling and the NLRP3 inflammasome to alleviate kidney injury and podocyte pyroptosis in DN.
Keywords: Diabetic nephropathy; Forkhead box M1; NLRP3 inflammasome; Nuclear factor-kappa B; Podocytes; Pyroptosis; Sirtuin 4.
Copyright © 2021 Elsevier Inc. All rights reserved.
Similar articles
-
Oxymatrine Attenuates High Glucose-induced NLRP3 Inflammasome-dependent Pyroptosis and Injury in Podocytes by Regulating SIRT1/NF-κB Pathway.Iran J Allergy Asthma Immunol. 2025 Mar 10;24(2):198-211. doi: 10.18502/ijaai.v24i2.18148. Iran J Allergy Asthma Immunol. 2025. PMID: 40211500
-
TRIM29 promotes podocyte pyroptosis in diabetic nephropathy through the NF-kB/NLRP3 inflammasome pathway.Cell Biol Int. 2023 Jun;47(6):1126-1135. doi: 10.1002/cbin.12006. Epub 2023 Feb 25. Cell Biol Int. 2023. PMID: 36841942
-
Astragaloside IV Alleviates Podocyte Injury in Diabetic Nephropathy through Regulating IRE-1α/NF-κ B/NLRP3 Pathway.Chin J Integr Med. 2025 May;31(5):422-433. doi: 10.1007/s11655-024-3568-0. Epub 2024 Jul 23. Chin J Integr Med. 2025. PMID: 39039342
-
A new research hot spot: The role of NLRP3 inflammasome activation, a key step in pyroptosis, in diabetes and diabetic complications.Life Sci. 2020 Jan 1;240:117138. doi: 10.1016/j.lfs.2019.117138. Epub 2019 Dec 4. Life Sci. 2020. PMID: 31809715 Review.
-
Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.Pharmacol Res. 2016 Dec;114:251-264. doi: 10.1016/j.phrs.2016.11.004. Epub 2016 Nov 5. Pharmacol Res. 2016. PMID: 27826011 Review.
Cited by
-
Why Is Longevity Still a Scientific Mystery? Sirtuins-Past, Present and Future.Int J Mol Sci. 2022 Dec 31;24(1):728. doi: 10.3390/ijms24010728. Int J Mol Sci. 2022. PMID: 36614171 Free PMC article. Review.
-
Clinical significance of NLRP3 inflammasome and related cell molecules in early diabetic kidney disease in elderly population.J Med Biochem. 2024 Nov 16;43(6):828-834. doi: 10.5937/jomb0-45950. J Med Biochem. 2024. PMID: 39876912 Free PMC article.
-
The Role of Sirtuins in Diabetic Nephropathy: A Comprehensive Review.Curr Protein Pept Sci. 2025;26(6):407-421. doi: 10.2174/0113892037340795241202044932. Curr Protein Pept Sci. 2025. PMID: 39844569 Review.
-
Inhibiting NLRP3 signaling in aging podocytes improves their life- and health-span.Aging (Albany NY). 2023 Jul 23;15(14):6658-6689. doi: 10.18632/aging.204897. Epub 2023 Jul 23. Aging (Albany NY). 2023. PMID: 37487005 Free PMC article.
-
NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies.Heliyon. 2024 Apr 18;10(9):e29871. doi: 10.1016/j.heliyon.2024.e29871. eCollection 2024 May 15. Heliyon. 2024. PMID: 38707342 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous